clinical trial · NCT07548632
A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
Oculis·phase3·recruiting·n = 160
Dry Eye Disease (DED)Artificial Tear Run-inlicaminlimabVehicle of licaminlimab
brief summary
The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of licaminlimab as compared to vehicle in participants with Dry Eye Disease and a specific genotype.
started
Apr 16, 2026
primary completion
Dec 1, 2026
completion
Dec 1, 2026
last updated
May 29, 2026
official title
A Phase 2b/3, Double-masked, Randomized, Vehicle-controlled, Multicenter Study Evaluating Licaminlimab in Dry Eye Disease Patients With a Specific TNFR1 Genotype
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol